Markus W. Schneider

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 48 publications

Allogeneic Transplantation in the Rare Disease Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Neutrophilia: Age and Disease Burden Determine Outcome.

Allogeneic Transplantation in the Rare Disease Myelodysplastic Syndrome/Myeloproliferative Neoplasm with Neutrophilia: Age and Disease Burden Determine Outcome.

Journal: Transplantation and cellular therapy

Published: April 10, 2026

Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome.

Allogeneic Transplantation in the rare disease MDS/MPN with Neutrophilia: Age and Disease Burden Determine Outcome.

Journal: Transplantation and cellular therapy

Published: April 10, 2026

Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10.

Prognostic Value of Molecular Genetic Measurable Residual Disease (MRD) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10.

Journal: European journal of haematology

Published: May 12, 2025

No evidence of leukaemia (NEL) as a response criteria in paediatric AML: a multicentre analysis.

No evidence of leukaemia (NEL) as a response criteria in paediatric AML: a multicentre analysis.

Journal: EClinicalMedicine

Published: November 27, 2024

Common origin and somatic mutation patterns of composite lymphomas and leukemias.

Common origin and somatic mutation patterns of composite lymphomas and leukemias.

Journal: Leukemia

Published: November 11, 2024

Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.

Author Correction: A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.

Journal: Communications biology

Published: September 11, 2024

Improved outcomes and treatment guidance in pediatric therapy-related AML: AML-BFM study group recommendations.

Improved outcomes and treatment guidance in pediatric therapy-related AML: AML-BFM study group recommendations.

Journal: Blood advances

Published: September 05, 2024

A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.

A MYCN-driven de-differentiation profile identifies a subgroup of aggressive retinoblastoma.

Journal: Communications biology

Published: December 13, 2023

Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia.

Panel-based RNA fusion sequencing improves diagnostics of pediatric acute myeloid leukemia.

Journal: Leukemia

Published: July 21, 2023

Understanding WT1 Alterations and Expression Profiles in Hematological Malignancies.

Understanding WT1 Alterations and Expression Profiles in Hematological Malignancies.

Journal: Cancers

Published: May 07, 2023

Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.

Treatment outcomes of childhood PICALM::MLLT10 acute leukaemias.

Journal: British journal of haematology

Published: March 01, 2023

RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group.

RUNX1 mutation has no prognostic significance in paediatric AML: a retrospective study of the AML-BFM study group.

Journal: Leukemia

Published: December 14, 2022

Showing 1-12 of 48

Last Updated: 09/26/2026